Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL

NCT05259813 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to the COVID-19 pandemic，no subjects enrolled

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

GENETIC: JWCAR029 (Relmacabtagene Autoleucel)

Sponsor

Shanghai Ming Ju Biotechnology Co., Ltd.

Collaborators

[object Object]